CompletedNot Applicable

Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus

France66 participantsStarted 2024-06-30

Plain-language summary

Isoflurane might be used as anticonvulsive therapy in refractory status epilepticus. The aim of the study is to assess the efficiency of Isoflurane in this indication.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 years, hospitalized in ICU between 2016-01-01 and 2023-01-01, suffering refractory status epilepticus treated by inhaled Isoflurane as third anticonvulsive therapy Exclusion Criteria: * post-anoxic refractory status epilepticus after cardiac arrest, withdrawal of consent for medical data use

What they're measuring

rate of crisis control

Timeframe: 3 months

Trial details

NCT IDNCT05830864

SponsorHopital of Melun

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-22

View on ClinicalTrials.gov More Refractory Status Epilepticus trials